510(K) CLEARANCES 84 ▲14RECALLS POSTED 39 ▲27CLASS I 6 ▲2PMA DECISIONS 47 ▲11WEEK ENDING / FDA DATA AS OF
Medical Device
ManufacturingTHE TRADE PAPER OF THE FACTORY FLOOR
SUBSCRIBE / SIGN IN
K831734Substantially Equivalent

Amoxapine 8-Hydro-Xyamoxapine

Utak Laboratories Inc, Mchenry IL / Traditional, Substantially Equivalent
FDA source (opens on fda.gov)

K831734 is the FDA 510(k) clearance record for AMOXAPINE 8-HYDRO-XYAMOXAPINE, a class I device, cleared for Utak Laboratories, Inc. on under FDA product code DIF (Drug Mixture Control Materials). FDA records list 23 510(k) clearances for Utak Laboratories, Inc., from to . As of , FDA records show no recalls naming K831734.

Clearance record

Decision date
Received
(56 days to decision)
Product code
DIF Drug Mixture Control Materials
Regulation
21 CFR 862.3280
Device class
Class I
Review panel
Clinical Toxicology
Applicant
Utak Laboratories, Inc. 803 N. Front St. Suite 3, Mchenry IL
Third party review
No

Clearances, product code DIF

Trailing 12 months

FDA records hold no clearances under product code DIF in the trailing twelve months.

FDA records show no clearances under product code DIF in the twelve months to October 2026.
Show the numbers
Monthly 510(k) clearances under FDA product code DIF, trailing twelve months
MonthClearances
November 20250
December 20250
January 20260
February 20260
March 20260
April 20260
May 20260
June 20260
July 20260
August 20260
September 20260
October 20260